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Introduction 54
Antibiotic resistance in pathogenic microbes has become one of the most serious threats to global health in 55 recent years. There is no doubt that we already have entered the "inactive antibiotics" era, with dozens of 56 multi-drug resistant bacteria. For example, β-lactam antibiotics, which are the most common class used 57 today, were the first medications developed to effectively treat bacterial infections, and are credited with 58 having saved innumerable lives [1] [2] [3] [4] . However, an unfortunate consequence of using these life-saving 59 antibiotics has been a steep rise in bacterial strains resistant to treatment. Many cases of penicillin-resistant 60 bacterial infections, as well as resistance to second-and third-generation antibiotics have been reported in 61 recent years [5, 6] . Thus, developing effective alternatives to treat bacteriogenic diseases is an urgent 62 clinical need [7] [8] [9] [10] [11] .
63
One method of bactericidal intervention may be to interrupt copper transfer through bacterial membranes.
64
Specific inhibition of components unique to bacterial transport systems could lead to bacterial death due to 65 intracellular accumulation of copper, which would accelerate the formation of reactive oxygen species and 66 enhance the Fenton reaction, thereby killing microbes [12] . Prokaryotic cells have four main mechanisms 67 for Cu(I) transport [13] : (i) the Cytoplasmic CueR-metal sensor, which initiates the transcription process of to less toxic Cu(II) [17] . Targeting CusCFBA and CueR systems for antibiotics research has a fundamental 73 advantage because they are only found in prokaryotic cells, and no homologs exist in eukaryotic cells. Thus, 74 targeting one of these two copper transport systems as antibiotics should operate solely on bacteria and 75 would not interfere with the human copper transport mechanism.
76
CueR is a metal sensor that senses the Cu(I) ion with high affinity and induces a transcription process [14,
77 18]. It is found in a large variety of microbes, but their structure and functionality vary among bacterial 78 species, meaning that a single compound will be applicable for a broad range of bacteria [19, 20] . By 79 contrast, CusCFBA efflux systems are less ubiquitous, but are found in many pathogenic microbes such as 80 Legionella, Salmonella, Klebsiella, Pseudomonas and many other Gram-negative bacteria. The sequence 81 identity among all species is about 30%.
82
The CusCFBA complex consists of an inner membrane proton-substrate carrier (CusA) and an outer 83 membrane protein (CusC). The inner and outer membrane proteins are connected by a linker protein CusB 84 in the periplasm, and are at an oligomerization ratio CusA:CusB:CusC of 3:6:3 which form a channel [21] .
85
The structure of the entire channel has not been resolved; however, the crystal structures of the individual 86 components (CusC, CusA, and CusB) and of the CusBA complex have been determined [22] [23] [24] [25] . It has 87 been suggested that the CusB-CusF interaction functions as the trigger for the entire CusCFBA efflux 88 system opening, galvanizing the transfer of Cu(I) to CusC [26, 27] . The crystal structure of CusB indicates 89 that the protein is folded into an elongated narrow structure and can be separated into four domains. The
90
first three domains are mostly β-strands, whereas the fourth forms a three-helix bundle [22, 24] . The most 91 studied region in CusB is the N-terminal domain (CusBNT), which comprises 61 amino acids (residues 28-92 88) that were shown to interact directly with CusF [28, 29] . CusBNT knockout studies have resulted in sequence π/2(ν obs )-τ 1 -π(ν obs )-t′−π(ν pump )-(τ 1 + τ 2 − t′)-π(ν obs )-τ 2 (ν obs )-τ 2 -echo was performed at (50 ± 0.5 K)
194 on a Q-band Elexsys E580 equipped with a 2-mm probe head; bandwidth, 220 MHz. A two-step phase 195 cycle was applied to the first pulse. The echo was measured as a function of t′, and τ 2 was kept constant to 196 eliminate relaxation effects. The pump pulse frequency was set to the maximum of the EPR spectrum and 197 the observer pulse frequency was set 60 MHz higher than that of the pump pulse. The observer π/2
198 and π pulses, as well as the π pump pulse, had durations of 40 ns; the dwell time was 10 ns. We suspected that this short peptide would interfere with the interaction between two 239 monomers of CusB, thereby impeding the ability of the channel to be physiologically active. However, this 240 13-amino acid peptide was too long and contained too many features. Thus, several overlapping, short 241 peptides were designed, based on the entire peptide sequence. To more empirically confirm our choice of 242 a potential inhibition area, we also identified potential binding sites for peptide binding using Schrodinger's 243 SiteMap [36] (Fig 1) . 
247
Based on these results, we defined the cavity area and designed a structure-based pharmacophore model by 248 using the receptor cavity protocol implemented in Schrodinger's Phase [39] (Fig 2) . 
253
The resulting pharmacophores were further refined by adding excluded volumes. Excluded volumes are 254 points in space occupied by protein atoms, which represent steric hindrances in the binding site. Such points 255 cannot be occupied by ligand atoms. This pharmacophore model was used for virtual screening of a peptide 256 library. These peptides were subjected to a conformational search procedure prior to the screening. The
257
conformations were subsequently fit to the pharmacophore models using flexible fitting methods. The 258 twenty highest ranked peptides, based on fit value, were chosen for validation with docking simulations.
259
The hit molecules, determined by the virtual screening, were refined [39] to determine whether these 260 chemical features were mapped with structure-based interaction mode. Ten peptides, sorted and chosen on 261 the basis of XP gscore, were chosen for synthesis and further evaluation ( Table 1) . All ten chosen peptides 262 were short subsequences of the parent peptide (pep1). The peptides were synthesized using Rink resin.
263
Several peptides were obtained in the purity level, which is below 95% (Table 1) , despite several attempts 264 to purify them. However, we conducted the preliminary screening of the peptides taking for consideration 265 the option that if some not pure enough peptide might be active, additional synthesis will be conducted.
266 
Effect of test peptides on E.coli viability 305
Live/dead fluorescence cell imaging experiments were used to indicate bacterial viability when incubated 306 with the peptides. This method also helped to determine whether the decrease in the growth rate described 307 above resulted from deceleration in E. coli growth or its substantial death. E coli were grown to the late lag 308 phase (according to the growth rate lines; Figs B to D in S1 file) in the presence of the peptides in poor 309 medium (M9), which mostly resembles physiological conditions.[52-54] Glucose levels in the growth 310 media were sufficient to prevent bacterial viability loss due to lack of nutrition, yet not too high to positively 311 affect its viability [55, 56] . A comparison of cell counts based on the images presented in Fig 4 (additional   312 images are presented in Figs G to K in S1 file) revealed a high correlation between the cytotoxic effect 313 caused by the peptides via Cu(II) homeostasis interference and E. coli death. Though a slight reduction in 314 bacteria viability was observed in the control sample, incubation of the bacteria with the peptides resulted 315 in a substantial cytotoxic effect (Fig 4) . However, the effect of the peptides was not as substantial as the 316 commercially available antibiotic kanamycin. Pep5 continuously reduced bacterial viability even at 50 µM; Cu(II) into the growth media. However, at 125 µM all peptides exhibited an effect independent of the 320 presence of Cu(II). These results indicated that E. coli viability might be affected by those peptides even at 321 the low copper concentration that naturally exists in growth media. Pep8 also exhibited a substantial 322 reduction of bacterial viability though not as much as pep5; the largest reduction of bacterial viability was 323 detected at a concentration of 125µM: 41 5.15%.
324
In order to verify that these peptides are specifically toxic to microbes and not to mammalian cells, we 325 carried out toxicity experiments (Fig M in S1 file) , which showed that even at 150 µM, highly differentiated 326 rat L6 myotubes remain alive. distribution between the four spin labels was used for the measurement (Fig 5) The need for innovative antibiotics with novel bactericidal mechanisms is increasing rapidly. We propose 388 an approach for developing novel antibiotics based on a unique molecular target: inhibition of the CusCFBA 389 efflux system. The CusCFBA efflux system within Gram-negative bacteria plays a crucial role in copper homeostasis within the bacteria, which is directly associated with bacterial viability. We focused here on 391 CusB, which represents a significant part of the efflux channel, and is responsible for initiating its opening 392 and for exporting copper ions to the extracellular domain [29, 32] . In one of our previous studies, we found 393 that CusB adopts a specific conformation in association with Cu(I) [33] . A physiologically active CusB 394 domain is a trimer of core dimers. We determined that domains 2 and 3 (two central domains) of CusB 395 undergoes major structural changes upon Cu(I) binding. More specifically, both domains are moved outside 396 of the channel and are exposed to binding with another CusB monomer. In addition, based on 397 crystallographic studies, the targeted region has been suggested to be highly flexible and therefore greatly 398 influences the entire structure of the channel [24] . We hypothesized that in the presence of the small, CusB-399 like peptide, the formation of the full channel would not occur properly. By combining molecular modeling, 400 magnetic resonance spectroscopy, and in vitro measurements, we have developed and tested a series of 401 peptides, two of which (pep5 and pep8) exhibited a cytotoxic effect in E. coli culture in a Cu-dependent 402 manner. Pep5 exhibited the greatest effect on cell growth and viability. Although we did not prove how and 403 where pep5 interacts with CusB, we have substantial circumstantial evidence for this interaction. Pep5 was 404 much more active in the presence of 5 µM Cu(II) in the growth media at all tested concentrations, indicating 405 that the copper efflux system within the bacteria was affected by the peptide. Pulsed EPR spectroscopy was 406 utilized to better validate this hypothesis, and the data suggest that pep5 targets the interference surface of 407 the CusB dimer by making structural changes, and that the native transformation between the apo to the 408 holo state of CusB no longer exists in the presence of the peptide. We believe that this peptide does not 409 affect the assembly of the whole transporter; however, in some way, and owing to its small size, it succeeds 410 to penetrate between two monomers of CusB and thus, to inhibit physiological structural changes of the 411 transporter upon copper stress. Accumulation of the copper most likely leads to oxidative stress via induced 412 Fenton reaction, culminating in reduced bacterial viability. Since the system is unique to bacteria and is 413 located across the periplasm of the bacteria, pep5 and future peptidomimetic derived compounds should be 414 able to inhibit CusB activity by only penetrating a single membrane, making the target more accessible for 415 inhibition.
416
Observing the large reduction in bacterial growth at a 125 µM concentration of pep5 even before the 417 addition of copper suggests that at high peptide concentrations, the bacteria lose their ability to cooperate 418 even with the minimal concentration of copper found in the bacterial growth media under physiological 419 conditions. We could hypothetically make such a statement because at an identical concentration 420 mammalian cells were not affected. Although the lowest effective concentration of pep5 is still a non-421 pharmacological concentration, we have conclusively shown that disruption of the Cu transport system in 422 bacteria can lead to a cytotoxic effect, a discovery that should be given further study for its implications in 423 treating antibiotic-resistant bacterial infections. We anticipate that pep5 can serve as a structural template 424 for developing novel more potent and effective pep5 based peptidomimetics to disrupt CusB function more 425 efficiently or even completely.
426
Such compounds may represent in the future a new class of antibiotics that can contribute to the fight against 427 antibiotic resistance.
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